A detailed history of Ehrlich Financial Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Ehrlich Financial Group holds 245 shares of LLY stock, worth $194,939. This represents 0.15% of its overall portfolio holdings.

Number of Shares
245
Previous 236 3.81%
Holding current value
$194,939
Previous $214 Million 1.58%
% of portfolio
0.15%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $6,949 - $8,640
9 Added 3.81%
245 $217 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $28,994 - $36,361
-40 Reduced 14.49%
236 $214 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $163,447 - $218,669
276 New
276 $215 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ehrlich Financial Group Portfolio

Follow Ehrlich Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ehrlich Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ehrlich Financial Group with notifications on news.